BGCS Thursday 5 th July. Time Session Location 7:30-9:20 Registration. 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford

Transcription

1 Thursday 5 th July Time Session Location 7:30-9:20 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Rutherford 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:20-9:30 Welcome and introduction Mr Tim Mould and Dr Rebecca Kristeleit Mountbatten 9:30-11:00 Treating relapsed disease Mountbatten 15 mins Why do ovarian cancers relapse? Dr James Brenton, Cancer Research UK Cambridge Institute Treatment of relapsed ovarian cancer Dr Rosalind Glasspool, University of Glasgow Complete surgical resection in relapsed disease: Insights from desktop 3 Prof Andreas Dubois, Kliniken Essen-Mitte, Germany Genetic mutations guiding treatment Prof Chris Lord, Institute of Cancer Research How do we access advanced tumour analysis across the UK Mountbatten 10:30-13:00 PARALLEL SESSION: Small Cell Ovarian Cancer Hypercalcemic Type (SCCOHT) (Please see page 5) Wesley 11:00-11:30 Coffee break

2 Thursday 5 th July 11:30-13:00 Surgical cancer techniques Mountbatten Laparoscopy to determine resectability of advanced ovarian cancer peritoneal resection and serosal deposits Advanced surgical procedures for recurrent cancer Prof David Cibula, Charles University Hospital, Prague Continent diversion techniques practicalities and pitfalls Dr Luis Chiva, University of Navarra, Madrid Sentinel nodes in cervical and endometrial cancer the place in management Dr Pernille Jensen, University of Southern Denmark 13:00-14:00 Lunch and poster viewing Exhibition 13:00-14:00 INDUSTRY SPONSORED SYMPOSIUM Rutherford 14:00-15:45 NCRI session Mountbatten Session to be lead by Prof Iain McNeish Session agenda to be made available shortly 14:00-15:45 PARALLEL SESSION: Unit Leads Rutherford Balanced communication of potential harms and benefits Histopathology of borderline tumours Dr Naveena Singh, Barts Health NHS Trust, London Surgical management of borderline tumours Prof Omer Devaja, Maidstone and Tunbridge Wells NHSFT 15:45-16:00 Coffee break and poster viewing Exhibition 16:00-17:30 Tumours with poor response to standard systemic therapies Mountbatten Targeting HPV in gynaecological cancers Dr Rowan Miller, Institute of Cancer Research London Metastatic granulosa cell tumours Dr Isabelle Ray-Coquard, CLCC Léon Bérard, France Low grade ovarian cancer clinical and molecular aspects Dr Douglas Levine, Memorial Sloan Kettering Cancer Centre End of day 1 17:30-23:00 Conference dinner (tickets must be booked in advance)

3 Friday 6 th July Time Session Location 7:30-8:50 Registration 8:00-9:00 INDUSTRY SPONSORED MEETING Burns 8:00-9:00 INDUSTRY SPONSORED MEETING Wesley 9:00-10:40 New opportunities for therapies Mountbatten Micro satellite instability practical applications in treatment Dr Yvette Drew, Northern Institute of Cancer Research, Newcastle HIPEC in Taiwan and the Netherlands DNA damage modulators and radiosensitisation Prof Anthony Chalmers, University of Glasgow Combining PARP and anti-angiogenesis in gynaecological cancers Dr Isabelle Ra-Coquard, CLCC Léon Bérard, France 10:40-11:10 Coffee break and poster viewing Exhibition 11:10-12:40 Proffered papers Mountbatten 6 x proffered papers to be presented 12:40-13:40 Lunch and poster viewing Exhibition 12:40-13:40 INDUSTRY SPONSORED SYMPOSIUM Rutherford

4 Friday 6 th July Time Session Location 13:40-15:30 Prevention Mountbatten 14:00-18:00 Aspirin, cancer, inflammation and the tumour micro-environment Prof Ruth Langley, University College London Hospital Inflammation and cancer 2: Statins prevention or promotion STIC and telomeres Dr Naveena Singh, Barts Health NHS Trust, London Extended genetic testing and GYN cancer risk Dr Zoe Kemp, The Royal Marsden Hospital, London Surgical prevention Screening for circulating tumour cells to diagnose ovarian cancer earlier after an abnormal ROCA score Prof Martin Widschwendter, University College London PARALLEL SESSION (Invite only): Devising an evidence based patient information leaflet for extensive surgery for ovarian cancer TBC ASCO 2018 Breaking News Prof Jonathan Ledermann, University College London Hospital Mountbatten Final Thoughts Mountbatten The Danish Model - Improving cancer survival in Denmark Dr Lene Lundvall, Copenhagen University Hospital Discrepancy of care across the UK Prof Sean Kehoe, University College Birmingham 16:30-17:30 Presentation of prizes Mountbatten Close of conference

5 SCCOHT Symposium, WESLEY ROOM - Thursday 5 th July Time Session 09:30-09:45 Registration Pre-session networking Opening of the Small Cell Ovarian Cancer Hypercalcemic Type Symposium (SCCOHT) Welcome and introduction to the Small Cell Ovarian Cancer Hypercalcemic Type Symposium (SCCOHT) Dr Marc Tischkowitz, University of Cambridge Pathological Aspects of SCCOHT Prof Glenn McCluggage, Belfast Health and Social Care Trust Unexpected role for Immuno-oncology in SCCOHT Dr Douglas Levine, NYU Langone Medical Center 11:45-12:00 Coffee break 12:00-13:30 Part 2 of the SCCOHT Symposium Uncovering druggable vulnerabilities of SCCOHT through functional genetics Dr Sidong Huang, McGill University, Canada De-BAFling the role of SMARCA4 mutations in SCCOHT development and the potential for therapeutic interventions Prof Bernard Weissman, University of North Carolina at Chapel Hill, USA Solving the genetics of SCCOHT Prof William Foulkes, McGill University Health Centre, Canada Interviews with the speakers 14:00-15:00 Lunch 15:00-16:00 Closed doors meeting End of session

6 NFGON Symposium, RUTHERFORD ROOM - Friday 6 th July Time Session 09:00-09:30 Registration 09:30-09:40 Welcome to the NFGON Symposium Helen Mandeville, President NFGON and Gynaecology Oncology Clinical Nurse Specialist, Gateshead Health NHS Foundation Trust Title TBC Julia Pugh, Macmillan Clinical Nurse Specialist Christie NHS Foundation Trust Health and Well Being Events Anuska Randolph-Stevens, Macmillan Support Worker and PhD Researcher in Health Psychology The Royal Marsden NHS Foundation Trust and University of Surrey Coffee Using co-production to improve pre and post-operative care for women Undergoing radical vulval surgery Julie Dodds, Macmillan Support Nurse, Gateshead Health NHS Foundation Trust Database (Title TBC) Katy Horton-Fawkes, Clinical Nurse Specialist and Dr Amit Patel, Consultant Gynaecology Oncologist Bristol Haematology and Oncology Centre Share your experiences Interactive Around the country Discussions End of symposium